NYSE · HIMS

Hims & Hers Health, Inc.

Healthcare · Medical - Care Facilities

$27.85▼ 3.33% ($0.96)at close

After hours$27.91▲ 0.23%7:58 PM ET

52-week

$13.74$65.30

What the market price implies · Reverse DCF

Historical revenue grew by 71.42%/yr over the past 4 years.

Selected forecast · Base scenario

19.61%/yr · actual 10-year annualized revenue growth

Year 1 growth: 40%

Market-implied · Base operating assumptions + edited margins

Unavailable · flat 10-year annualized revenue growth

Reverse DCF solves revenue growth itself using Base operating assumptions and your edited margins. Changing forecast growth alone does not change the implied rate. This is a model-implied requirement, not an analyst forecast.

No supported revenue growth rate matches this price with these operating assumptions.

Valuation

Recommended · Revenue & margin DCF

Price used

$27.85

Estimated value / share

Unavailable

Base scenario

USD · TTM ending 2026-06-30

Every projected year produces negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.

Latest quarterly growth differs materially from the latest annual pace. It remains an observed growth input; review whether acceleration or a change in the business explains it.

Year 1 growth 40% · Ending margin 0% · Discount rate 15.68%

Assumption scenarios, not statistical confidence intervals.

Method, dates & sources

Estimated from future revenue, operating margins, and the investment needed to support them.

Price timestamp: Sep 15, 2026, 8:00 PM UTC
Financial statement period: TTM ending 2026-06-30
Data refreshed: Sep 16, 2026, 3:40 AM UTC · provider

Why this method?

There is not a stable run of positive FCFF to anchor a direct cash-flow CAGR, so the model should start from revenue and margin assumptions instead.

Is FCFF positive and has it been for 3+ consecutive years? Latest FCFF is not positive.

Price vs Fundamentals

Why The Stock Is Moving

Mixed / unclearLow confidence

1Y Price: -48.42%Revenue (TTM): 28.04%FCF (TTM): -24.79%P/FCF: 67th pct

What changed

The stock fell 48.42% over the last year. Revenue grew 28.04% over the trailing twelve months. Operating margin moved from 6.24% to -3.59%. Free cash flow declined 24.79% over the trailing twelve months.

What the market seems to be pricing

The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.

What would invalidate this read

Operating margin currently stands at -3.59%. A decisive move in revenue — currently up 28.04% — would be the clearest signal to resolve the ambiguity.

Performance

Return analysis

Company profile

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care.

CEOAndrew Dudum

SectorHealthcare

IndustryMedical - Care Facilities

Employees2,442

IPO dateSep 13, 2019

https://www.hims.com

Market multiples

Forward P/E—

EV/EBITDA45.94

Enterprise value$8.2B

Stock splits

No stock splits recorded for this ticker.

Profitability & growth

Revenue growth38.25%

Gross margin (FY2025)73.84%▼5.6ppvs FY2024

Operating margin (FY2025)4.5%▲0.3ppvs FY2024

ROE-32.03%▼57.3ppvs FY2025

Analyst consensus

RatingHold

Target price$32.17▲15.51%

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 9, 2026

Q4 FY26 · EPS est $0.08 · Revenue est $892.62M

View